Form D — Onconetix, Inc.
0001465818-25-000010 · filed Oct 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $12,977,670
- Reported amount sold
- $12,977,670
- Minimum investment
- $208,823
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Onconetix, Inc.
- CIK
- 1782107
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 201 E. FIFTH STREET
CINCINNATI, Ohio 45202 - Phone
- 513-620-4101
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Karina Fedasz · Executive OfficerCincinnati, Ohio Find on LinkedIn ↗
-
Simon Tarsh · DirectorCincinnati, Ohio Find on LinkedIn ↗
-
Timothy Ramdeen · DirectorCincinnati, Ohio Find on LinkedIn ↗
-
Thomas Meier · DirectorCincinnati, Ohio Find on LinkedIn ↗
-
Andrew Oakley · DirectorCincinnati, Ohio Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗